BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qiu T, Wang Y, Liang S, Han R, Toumi M. The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects. Drug Discov Today 2021:S1359-6446(21)00207-5. [PMID: 33892148 DOI: 10.1016/j.drudis.2021.04.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu K, Zhang X, Hu Y, Chen W, Kong X, Yao P, Cong J, Zuo H, Wang J, Li X, Wei B. What, Where, When and How of COVID-19 Patents Landscape: A Bibliometrics Review. Front Med 2022;9:925369. [DOI: 10.3389/fmed.2022.925369] [Reference Citation Analysis]
2 Qiu T, Pochopien M, Liang S, Saal G, Paterak E, Janik J, Toumi M. Gene Therapy Evidence Generation and Economic Analysis: Pragmatic Considerations to Facilitate Fit-for-Purpose Health Technology Assessment. Front Public Health 2022;10:773629. [PMID: 35223725 DOI: 10.3389/fpubh.2022.773629] [Reference Citation Analysis]
3 Pochopień M, Qiu T, Aballea S, Clay E, Toumi M. Considering potential solutions for limitations and challenges in the health economic evaluation of gene therapies. Expert Rev Pharmacoecon Outcomes Res 2021;:1-14. [PMID: 34407704 DOI: 10.1080/14737167.2021.1969229] [Reference Citation Analysis]